ArticlePlants (Basel, Switzerland)2024
Medicinal Plants Used to Treat Skin Diseases and for Cosmetic Purposes in Norway.
Article in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development of a metabolomic LC-QTOF method for bioactive compound production control in plant cell cultures.Analytical and bioanalytical chemistry · 2026Article
- Medicinal Plants for Dermatological and Cosmetic Applications: Ethnobotanical Study from Northern Lithuania.Plants (Basel, Switzerland) · 2026Article
- Editorial on Special Issue "Advances in Natural Products for Cutaneous Application".Pharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin diseases in Norway represents an important area of study due to their incidence and prevalence, yet ethnobotanical research in this context remains scarce. The aim of this study was to evaluate the knowledge of Norwegian traditional medicine regarding the treatment of skin diseases and cosmetic purposes through a comparative analysis with EMA monographs. Participants were surveyed using semi-structured interviews. The two samples comprised 22 individuals from Bodø and 26 individuals from other Norwegian communities, all of whom use medicinal plants for the treatment of skin diseases and cosmetic purposes. The indications for skin diseases identified in the study were compared with the European Union herbal monographs published by the European Medicines Agency. Fieldwork was conducted between June 2022 and September 2023, during which 42 plant species from 22 families were recorded. More than half of these plant species (65.38%) were used without European Medicines Agency-approved medical indications. From a public safety perspective, ensuring the safety of self-treatment for skin diseases is a critical research focus for future ethnobotanical studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.